Literature DB >> 3177415

Cyclosporin for central nervous system sarcoidosis.

D Cunnah1, S Chew, J Wass.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3177415     DOI： 10.1016/s0002-9343(88)80106-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

1.  Clinical course after liver transplantation in patients with sarcoidosis.

Authors:  F A Casavilla; R Gordon; H I Wright; J S Gavaler; T E Starzl; D H Van Thiel
Journal:  Ann Intern Med       Date:  1993-06-01       Impact factor: 25.391

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

3.  Central neurotoxicity of cyclosporine in two children with nephrotic syndrome.

Authors:  Sophie Taque; Sylviane Peudenier; Sophie Gie; Marc Rambeau; Virginie Gandemer; Laure Bridoux; Pierre Bétrémieux; Loic De Parscau; Edouard Le Gall
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

Review 4.  Endocrine aspects of neurosarcoidosis.

Authors:  G Murialdo; G Tamagno
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.